Meyka AI API is live for developers.Start building.
Advertisement
XOMA Royalty Corporation

XOMA Royalty Corporation (XOMAP) Stock Overview

Explore XOMA Royalty Corporation’s financial performance, market position, analyst ratings, and future outlook.

XOMAP●NASDAQ
HealthcareMedical - Pharmaceuticals
$25.49
$0.03(0.12%)
U.S. Market opens in 53h 30m
Advertisement

XOMA Royalty Corporation (XOMAP)

Meyka AI Score

Z

Key Financials

Market Cap307.5M
P/E Ratio15.45
EPS (TTM)$1.82
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$25.59
3 Months$25.47
1 Year Target$26.61

XOMAP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of XOMA Royalty Corporation (XOMAP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.45 and a market capitalization of 307.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.12%
5-Day Change
0.20%
1-Month Change
0.51%
3-Month Change
-0.43%
6-Month Change
-4.71%
Year-to-Date (YTD) Change
-5.14%
1-Year Change
-0.66%
3-Year Change
5.72%
5-Year Change
-2.15%
All-Time (Max) Change
4.42%

Contact Information

https://www.xoma.com
510 204 7200
2200 Powell Street, Emeryville, CA, 94608

Company Facts

140 Employees
IPO DateDec 16, 2020
CountryUS
Actively Trading

Frequently Asked Questions